Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
Clinical trial NCT02335879 · COMPLETED
Trial details
- NCT number
- NCT02335879
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-08-01
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.